Astria Therapeutics Inc (ATXS NASDAQ) stock market data APIs
$12.5546
0(0%)
as of November 20, 2025
Try our APIs with
free plan!
Astria Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Astria Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. Its lead product candidate is navenibart, a monoclonal antibody inhibitor of plasma kallikrein, which is in Phase 1b/2 clinical trials for the treatment of hereditary angioedema. The company is also developing STAR-0310, a monoclonal antibody OX40 antagonist that is in clinical development for the treatment of atopic dermatitis, an immune disorder associated with loss of skin barrier function and itching. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is headquartered in Boston, Massachusetts.
Prev. Close
12.5546
Open
12.5595
High
12.6042
Low
12.4795
52 wk Range
3.555-12.715
Market Cap
710 M
Shares Outstanding
57 085 K
Revenue
706 K
EPS
-0.55
Beta
0.075
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Astria Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Astria Therapeutics Inc data using free add-ons & libraries
Get Astria Therapeutics Inc Fundamental Data
Astria Therapeutics Inc Fundamental data includes:
- Net Revenue: 706 K
- EBITDA: -32 380 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: -0.4188
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Astria Therapeutics Inc News
New
Why Analysts Say the BioCryst Story Is Changing After Astria Therapeutics Acquisition
BioCryst Pharmaceuticals' stock narrative shifted recently as analysts adjusted their fair value estimate from $20.27 to $19.73 per share. This modest decrease follows the company’s acquisition of A...
Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
-- BioCryst’s Acquisition of Astria Expected to Close in the First Quarter of 2026 -- -- Phase 3 ALPHA-ORBIT Trial for Navenibart is Progressing as Planned with Topline Results Anticipated in Early...
BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update
BioCryst Pharmaceuticals, Inc. —Q3 2025 ORLADEYO net revenue of $159.1 million (+37 percent y-o-y)— —Q3 2025 operating profit of $29.6 million (+285 percent y-o-y); non-GAAP operating profit o...
Astria, Viridian Therapeutics, and More Stocks See Action From Activist Investors
13D FILINGS These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities. Continue Reading View Comments
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
